No headlines found.
No press releases found.
No news found.
The Fund's investment objective is to provide investors with returns that match the price return of the SPDR S&P 500 ETF Trust up to a predetermined upside cap while providing a downside buffer against the first 12% (before fees and expenses) of the SPDR S&P 500 ETF Trust's losses over the Target Outcome Period. In seeking to achieve this investment objective, the Fund's upside cap over the period May 10, 2024 through July 31, 2024 is 3.20%. Under normal market conditions, the Fund will invest at least 80% of its net assets in investments that provide exposure to equity securities issued by large-capitalization U.S. companies. The Fund is an actively managed exchange-traded fund ("ETF").
SHL Telemedicine Pgim US Large-Cap Buffer 12 ETF - August trades on the BATS stock market under the symbol AUGP.
As of December 12, 2024, AUGP stock price was flat at $27.50 with million shares trading.
AUGP has a market cap of $3.85 million. This is considered a Sub-Micro Cap stock.
AUGP support price is $27.42 and resistance is $27.58 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AUGP shares will trade within this expected range on the day.